The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 3-4, 1999, Pages 166-173

  Grothey, A ^a   Voigt, W ^a   Schober C ^a   Muller T ^a   Dempke, W ^a   Schmoll, H J ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Apoptosis; IGF; Signaling; Transformation Chemosensitivity

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL TRANSFORMATION; CHEMOSENSITIVITY; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS; RECEPTOR, IGF TYPE 1;

EID: 0032909323     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050259     Document Type: Article

References (77)

1. Aas T, Borresen AL, Geisler S, Smith Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PE (1996) Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2:811-814
2. Abbott AM, Bueno R, Pedrini MT, Murray JM, Smith RJ (1992) Insulin-like growth factor I receptor gene structure. J Biol Chem 267:10 759-10 763
3. Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C (1995) Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substance-1. J Biol Chem 270:14 685-14 692
4. Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
5. Barry MA, Behnke CA, Eastman A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthernia, Biochem Pharmacol 40:2353-2362
6. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:F105-126
7. Brancolini C, Lazarevic D, Rodriguez J, Schneider C (1997) Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin. J Cell Biol 139:759-771
8. Buckbinder L, Talbott R, Velasco Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
9. Burgaud JL, Resnicoff M, Baserga R (1995) Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun 214:475-481
10. Burger H, Nooter K, Boersma AW, Kortland CJ, stoter G (1998) Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Br J Cancer 77:1562-1567
11. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R (1994) A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14:4588-4595
12. Craparo A, O'Neill TJ, Gustafson TA (1995) Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor. J Biol Chem 270:15 639-15 643
13. DeAngelis T, Ferber A, Baserga R (1995) Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J Cell Physiol 164:214-221
14. D'Ambrosio C, Ferber A, Resnicoff M, Baserga R (1996) A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res 56:4013-4020
15. D'Mello SR, Galli C, Ciotti T, Calissano P (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 90:10 989-10 993
16. Dunn SE, Hardman RA, Kari FW, Barrett JC (1997) Insulin-like growth factor I (IGF-1) alters grug sensitivity of HBL 100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 57:2687-2693
17. Dunn TA, Schmoli HJ, Grunewald V, Hartmann K, Casper J (1998) Secretion of IGF-I by NSGCT cell lines and effect of IGF-I receptor neutralising monoclonal antibody on NSGCT growth in vitro and nude mouse xenografts. In: Jones WG, Appleyard I, Hamden P, Joffe JK (eds) Germ cell tumour. IV. Libbey, London, pp 55-68
18. Eastman A (1987) The formation, isolation and characterization of DNA addducts produced by anticancer platinum complexes. Pharmacol ther 34:155-166
19. Eastman A (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2:275-280
20. Egan SE, Weinberg RA (1993) The pathway to signal achievement. Nature 365:781-783
21. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128
22. Fei ZL, D'Ambrosio C, Li S, Surmacz E, Baserga R (1995) Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol Cell Biol 15:4232-4239
23. Feldkamp MM, Lau N, Guha A (1997) Signal transduction pathways and their relevance in human astrocytomas. J Neurooncol 35:223-248
24. Flossmann-Kast BB, Jehle PM, Hoeflich A, Adler G, Lutz MP (1998) Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Cancer Res 58:3551-3554
25. Fritsche M, Haessler C, Brandner G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307-318
26. Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C, Nikolics K (1992) A role for IGF-1 in the rescue of CNS neurons following hypotoxicischemic injury. Biochem Biophys Res Commun 182:593-599
27. Gumbiner BM, McCrea PD (1993) Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl 17:155-158
28. Guvakova MA, Surmacz E (1997) Overexpressed IGF-I receptors reduce estrigen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 231:149-162
29. Hofbauer S, Hamilton G, Theyer G, Wollmann K, Gabor F (1993) Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines. Eur J Cancer 2:241-245
30. Johnston JA, Wang LM, Hanson EP, Sun XJ, White MF, Oakes SA, Pierce JH, O'Shea JJ (1995) Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J Biol Chem 270:28 527-28 530
31. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endoer Rev 16:3-34
32. Kalebic T, Tsokos M, Helman LJ (1994) In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2. Cancer Res 54:5531-5534
33. Kalebic T, Blakesley V, Slade C, Plasschaert S, Leroith D, Helman LJ (1998) Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R. Int J Cancer 76:223-227
34. Kaleko M, Rutter WJ, Miller AD (1990) Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10:464-473
35. Kato H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D (1994) Essential role of tyrosine residues 1131, 1135 and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol 8:40-50
36. Kuroda H, Mandai M, Konishi I, Yura Y, Tsuruta Y, Hamid AA, Nanbu K, Matsushita K, Mori T (1998) Human chorionic gonadotropin (hGG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of insulin-like growth factor-1 by hCG. Int J Cancer 76:571-578
37. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC (1994) Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE, Nature 371:346-347
38. Leof EB, Wharton W, Wyk JJ Van, Pledger WJ (1982) Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells. Exp Cell Res 141:107-115
39. Li S, Resnicoff M, Baserga R (1996) Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J Biol Chem 271:12 254-12 260
40. Liu D, Zong CS, Wang LH (1993a) Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signalling functions. J Virol 67:6935-6840
41. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstrstiadis A (1993b) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I IGF receptor (Igf1r). Cell 75:59-72
42. Long L, Navab R, Brodt P (1998) Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res 58:3243-3247
43. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967
44. Miura M, Li S, Baserga R (1995a) Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res 55:663-667
45. Miura M, Surmacz E, Burgaud JL, Baserga R (1995b) Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem 270:22 639-22 644
46. Morrione A, DeAngelis T, Baserga R (1995) Failure of the bovine papillomavirus to tranform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J Virol 69:5300-5303
47. Morrione A, Valentinis B, Li S, Ooi JY, Margolis B, Baserga R (1996) Grb10: a new substrate of the insulin-like growth factor I receptor. Cancer Res 56:3165-3167
48. Myers MG, Jr., Grammer TC, Wang LM, Sun XJ, Pierce JH, Blenis J, White MF (1994) Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. J Biol Chem 269:28 783-28 789
49. O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA (1997) Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 17:427-435
50. Oh Y (1998) IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res Treat 47:283-293
51. Ohlsson C, Kley N, Werner H, LeRoith D (1998) p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 139:1101-1107
52. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR (1995) 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J Biol Chem 270:24 670-24 673
53. Pietrzkowski A, Sell C, Lammers R, Ullrich A, Baserga R (1992) Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol 12:3883-3889
54. Pollak MN (1998) Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat 47:209-217
55. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D, Baserga R (1992) The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor. Mol Cell Biol 12:5069-5077
56. Reiss K, Porcu P, Sell C, Pietrzkowski Z, Baserga R (1992) The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene 7:2243-2248
57. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R (1994) Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54:4848-4850
58. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R (1995) Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55:3739-3741
59. Rodriguez Tarduchy G, Collins MK, Garcia I, Lopez Rivas A (1992) Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 149:535-540
60. Salmon WD, Daughday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation. J Lab Clin Med 49:825-836
61. Schwartzberg PL (1998) The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene 17:1463-1468
62. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90:11 217-11 221
63. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R (1994) Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612
64. Sell C, Baserga R, Rubin R (1995) Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 55:303-306
65. Sepp-Lorenzino L (1998) Structure and function of the insulin-like growth factor I receptor. Breast Cancer Res Treat 47:235-253
66. Sun XJ, Rothenberg P, Kaha CR, Backer JM Araki E, Wilden PA, Cahill DA, Goldstein BJ, white MF (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77
67. Valentinis B, Morrione A, Taylor SJ, Baserga R (1997) Insulin-like growth factor I receptor signaling in transformation by src oncogenes. Mol Cell Biol 17:3744-3754
68. Villa P, Kaufmann SH, Earnshaw WC (1997) Caspases and caspase inhibitors. Trends Biochem Sci 22:388-393
69. Vuori K, Ruoslahti E (1994) Association of insulin receptor substrate-1 with integrins. Science 266:1576-1578
70. Wang L, Ma W, Markovich R, Lee WL, Wang PH (1998) Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 139:1354-1360
71. Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL (1996) Repression of th insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 56:2781-2788
72. White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem 269:1-4
73. Wu Y, Tewari M, Cui S, Rubin R (1996) Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death. J Cell Physiol 168:499-509
74. Yamamoto K, Altschuler D, Wood E, horlick K, Jacobs S, Lapetina EG (1992) Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J Biol Chem 267:11 337-11 343
75. Yoshinouchi M, Baserga R (1993) The role of the IGF-1 receptor in the stimulation of cells by pulses of growth factors. Cell Prolif 26:139-146
76. Zamble DB, Jacks T, Lippard SJ (1998) p53-dependent and -independent responses to cisplatin mouse testicular teratocarcinoma cells. Proc Natl Acad Sci USA 95:6163-6168
77. Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ, Seth P, Helman LJ (1996) Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis. Cancer Res 56:1367-1373